tiprankstipranks
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market

Immunotech Biopharm Ltd (6978) Financial Statements

Compare
0 Followers

Immunotech Biopharm Ltd Financial Overview

Immunotech Biopharm Ltd's market cap is currently HK$1.90B. The company's EPS TTM is HK$-0.649; its P/E ratio is ―; Immunotech Biopharm Ltd is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Income¥ -230.55M¥ -280.24M¥ -333.35M¥ -419.83M¥ -110.14M
EBITDA¥ -178.83M¥ -236.16M¥ -324.33M¥ -333.99M¥ -86.79M
Net Income¥ -334.82M¥ -352.83M¥ -375.49M¥ -458.34M¥ -107.71M
Balance Sheet
Cash & Short-Term Investments¥ 176.97M¥ 79.46M¥ 353.34M¥ 845.39M¥ 282.25M
Total Assets¥ 846.28M¥ 879.44M¥ 1.10B¥ 1.21B¥ 416.97M
Total Debt¥ 457.17M¥ 149.81M¥ 111.05M¥ 51.06M¥ 39.00M
Net Debt¥ 405.01M¥ 91.36M¥ -242.29M¥ -794.33M¥ -243.25M
Total Liabilities¥ 675.39M¥ 373.07M¥ 274.51M¥ 81.38M¥ 246.64M
Stockholders' Equity¥ 173.62M¥ 508.44M¥ 822.26M¥ 1.13B¥ 168.94M
Cash Flow
Free Cash Flow¥ -186.17M¥ -277.49M¥ -435.89M¥ -339.34M¥ -116.49M
Operating Cash Flow¥ -163.63M¥ -180.92M¥ -254.65M¥ -263.67M¥ -95.47M
Investing Cash Flow¥ -116.60M¥ 23.38M¥ -328.21M¥ -204.07M¥ 25.74M
Financing Cash Flow¥ 273.92M¥ -36.06M¥ -11.00M¥ 1.05B¥ 217.21M
Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History

Immunotech Biopharm Ltd Debt to Assets

Immunotech Biopharm Ltd Cash Flow

Immunotech Biopharm Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis